학술논문

Transition from Basal Bolus to Once-Weekly Subcutaneous Semaglutide and Basal Insulin in Patients with Type 2 Diabetes Mellitus (TRANSITION-T2D)-A Prospective Randomized Controlled Trial
Document Type
Journal
Source
DIABETES; JUN 2023, 72 2p. Supplement: 1
Subject
Language
English
ISSN
1939327X